LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 17.28 | 27.76 | 8 | 838 | 0.0095 | -0.2235 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 17.28 | 27.76 | 1311 | 838 | 1.5631 | 1.1902 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 17.28 | 27.76 | 862 | 838 | 1.0278 | 1.0112 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 17.28 | 27.76 | 1173 | 838 | 1.3986 | 1.1412 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 18.98 | 27.76 | 6 | 941 | 0.0064 | -0.2602 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 18.98 | 27.76 | 1400 | 941 | 1.4876 | 1.1625 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 18.98 | 27.76 | 1123 | 941 | 1.1932 | 1.0707 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 18.98 | 27.76 | 1267 | 941 | 1.3462 | 1.1205 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 20.68 | 27.76 | 12 | 1119 | 0.0107 | -0.1455 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 20.68 | 27.76 | 1493 | 1119 | 1.3342 | 1.1111 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 20.68 | 27.76 | 1239 | 1119 | 1.1072 | 1.0386 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 20.68 | 27.76 | 1397 | 1119 | 1.2484 | 1.0850 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 22.39 | 27.76 | 17 | 1305 | 0.0130 | -0.0845 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 22.39 | 27.76 | 1614 | 1305 | 1.2361 | 1.0778 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 22.39 | 27.76 | 1403 | 1305 | 1.0745 | 1.0260 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 22.39 | 27.76 | 1487 | 1305 | 1.1388 | 1.0474 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.09 | 27.76 | 20 | 1461 | 0.0137 | -0.0557 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.09 | 27.76 | 1763 | 1461 | 1.2062 | 1.0666 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.09 | 27.76 | 1567 | 1461 | 1.0721 | 1.0245 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.09 | 27.76 | 1626 | 1461 | 1.1124 | 1.0376 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 25.79 | 27.76 | 15 | 1605 | 0.0093 | -0.0998 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 25.79 | 27.76 | 1844 | 1605 | 1.1488 | 1.0480 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 25.79 | 27.76 | 1670 | 1605 | 1.0404 | 1.0136 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 25.79 | 27.76 | 1727 | 1605 | 1.0759 | 1.0252 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 27.49 | 27.76 | 25 | 1723 | 0.0145 | -0.0174 | MN20160318_Q01 | I15 |